Literature DB >> 12834460

Psoriasis-like dermoscopic pattern of clear cell acanthoma.

Leonardo Bugatti1, Giorgio Filosa, Paolo Broganelli, Carlo Tomasini.   

Abstract

BACKGROUND: Dermoscopy provides additional criteria for the diagnosis of skin lesions.
OBJECTIVE: To investigate the dermoscopic aspect of clear cell acanthoma (CCA).
METHODS: Six consecutive cases of CCAs were observed under conventional dermoscopy (Case 1-4) or videodermoscopy (Case 5-6).
RESULTS: Common dermoscopic findings were: (i) squamous surface with translucid collarette; (ii) dilated capillary loops, mainly perpendicularly orientated to the skin surface, as dotted, pinpoint-like structures, regularly distributed in a reticular array over the surface.
CONCLUSIONS: The vascular psoriasis-like dermoscopic findings seem to be a clue for CCA and provide evidence of an inflammatory process for CCA formation.

Entities:  

Mesh:

Year:  2003        PMID: 12834460     DOI: 10.1046/j.1468-3083.2003.00754.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  5 in total

1.  [Red papule with collarette scale on thigh].

Authors:  J Dupont; K S Culpepper; C Curiel-Lewandrowski
Journal:  Hautarzt       Date:  2013-08       Impact factor: 0.751

2.  Multiple eruptive clear cell acanthoma.

Authors:  Paola Monari; Camillo Farisoglio; Giulio Gualdi; Giorgio Botali; Marco Ungari; Piergiacomo Calzavara-Pinton
Journal:  J Dermatol Case Rep       Date:  2010-11-19

3.  Hemosiderotic clear-cell acanthoma: a pigmented mimicker.

Authors:  Leonardo Bugatti; Giorgio Filosa
Journal:  Indian J Dermatol       Date:  2011-07       Impact factor: 1.494

Review 4.  Vascular structures in dermoscopy.

Authors:  Erhan Ayhan; Derya Ucmak; ZeynepMeltem Akkurt
Journal:  An Bras Dermatol       Date:  2015 Jul-Aug       Impact factor: 1.896

5.  Topical calcipotriol as a new therapeutic option for the treatment of clear cell acanthoma.

Authors:  Gaetano Scanni; Giovanni Pellacani
Journal:  An Bras Dermatol       Date:  2014 Sep-Oct       Impact factor: 1.896

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.